- Home
- KALV vs TCBX Comparison
KALV vs TCBX Comparison
Compare KALV & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- TCBX
- Stock Information
- Founded
- KALV N/A
- TCBX 2008
- Country
- KALV United States
- TCBX United States
- Employees
- KALV N/A
- TCBX N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- TCBX Banks
- Sector
- KALV Health Care
- TCBX Finance
- Exchange
- KALV Nasdaq
- TCBX Nasdaq
- Market Cap
- KALV 563.1M
- TCBX 454.9M
- IPO Year
- KALV N/A
- TCBX 2021
- Fundamental
- Price
- KALV $12.00
- TCBX $29.15
- Analyst Decision
- KALV Strong Buy
- TCBX Hold
- Analyst Count
- KALV 8
- TCBX 4
- Target Price
- KALV $24.83
- TCBX $36.67
- AVG Volume (30 Days)
- KALV 729.1K
- TCBX 81.9K
- Earning Date
- KALV 03-12-2025
- TCBX 04-23-2025
- Dividend Yield
- KALV N/A
- TCBX N/A
- EPS Growth
- KALV N/A
- TCBX 40.59
- EPS
- KALV N/A
- TCBX 2.78
- Revenue
- KALV N/A
- TCBX $165,678,000.00
- Revenue This Year
- KALV N/A
- TCBX $17.61
- Revenue Next Year
- KALV N/A
- TCBX $6.52
- P/E Ratio
- KALV N/A
- TCBX $10.48
- Revenue Growth
- KALV N/A
- TCBX 17.16
- 52 Week Low
- KALV $7.30
- TCBX $18.26
- 52 Week High
- KALV $15.50
- TCBX $39.45
- Technical
- Relative Strength Index (RSI)
- KALV 55.34
- TCBX 39.80
- Support Level
- KALV $11.42
- TCBX $26.46
- Resistance Level
- KALV $12.35
- TCBX $29.32
- Average True Range (ATR)
- KALV 0.96
- TCBX 2.05
- MACD
- KALV 0.04
- TCBX -0.04
- Stochastic Oscillator
- KALV 88.74
- TCBX 46.50
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.